Andrea Suranyi | Obstetrics | Best Researcher Award

Published on by Global Scholar Awards

Dr. Andrea Suranyi | Obstetrics | Best Researcher Award

Associated Professor| University of Szeged | Hungary

Dr. Andrea Suranyi is a researcher at the University of Szeged (Szegedi Tudományegyetem, SZTE), Hungary, whose scholarly work reflects a strong and consistent contribution to her field at both national and international levels. She has authored 67 scientific publications, including 62 peer-reviewed journal articles, one book chapter, and four conference papers, with the majority—40 papers—published in internationally recognized foreign journals. Her research has garnered 339 citations, of which 271 are independent, and she maintains a Hirsch index of 10 (11 total), evidencing the influence and sustainability of her academic impact. Beyond her core research output, Dr. Surányi has produced 137 abstracts, 72 additional scientific works, and several educational and outreach-oriented publications, demonstrating her active engagement in both specialized and public scientific communication. She has also contributed to higher education through two Hungarian-language university textbooks and four educational materials, emphasizing her dedication to knowledge transfer and academic mentorship. Her work spans multiple disciplines, with a focus on fostering collaboration, advancing research visibility, and strengthening connections between Hungarian and international scientific communities. Through her sustained publication record, interdisciplinary approach, and commitment to education, Dr. Surányi has established herself as a respected scholar whose research and teaching continue to shape and inspire scientific inquiry and intellectual development in Hungary and beyond.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

Koreck, A., Surányi, A., Szöny, B. J., Farkas, A., Bata-Csörgő, Z., & Kemény, L. (2002). CD3⁺CD56⁺ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clinical & Experimental Immunology, 127(1), 176–182. Cited by 98

Bede, O., Surányi, A., Pintér, K., Szlávik, M., & Gyurkovits, K. (2003). Urinary magnesium excretion in asthmatic children receiving magnesium supplementation: A randomized, placebo-controlled, double-blind study. Magnesium Research, 16(4), 262–270. Cited by 51

Bede, O., Nagy, D., Surányi, A., Horváth, I., Szlávik, M., & Gyurkovits, K. (2008). Effects of magnesium supplementation on the glutathione redox system in atopic asthmatic children. Inflammation Research, 57(6), 279–286. Cited by 50

Surányi, A., Kozinszky, Z., Molnár, A., Nyári, T., Bitó, T., & Pál, A. (2013). Placental three-dimensional power Doppler indices in mid-pregnancy and late pregnancy complicated by gestational diabetes mellitus. Prenatal Diagnosis, 33(10), 952–958. Cited by 37

Jakó, M., Surányi, A., Kaizer, L., Németh, G., & Bártfai, G. (2019). Maternal hematological parameters and placental and umbilical cord histopathology in intrauterine growth restriction. Medical Principles and Practice, 28(2), 101–108. Cited by 32

Dr. Andrea Surányi’s research advances understanding of immunological, metabolic, and perinatal health processes, bridging clinical science with practical healthcare outcomes. Her work contributes to improved diagnostic and therapeutic approaches in dermatology, pediatrics, and obstetrics, fostering evidence-based innovation and enhancing maternal and child health on a global scale.

Gwendolyn Quinn | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Gwendolyn Quinn | Medicine and Dentistry | Best Researcher Award

Professor| New York University| United States

Dr. Gwendolyn P. Quinn is an internationally recognized behavioral scientist and bioethicist whose research focuses on patient–provider communication, reproductive ethics, and quality of life among cancer patients, particularly adolescents, young adults, and sexual and gender minority populations. She is Professor and Vice Chair of Research in the Departments of Obstetrics and Gynecology and Population Health at the New York University Grossman School of Medicine, where she also holds the Livia Wan Endowed Chair and is a member of the Division of Medical Ethics and the Perlmutter Cancer Center. Dr. Quinn’s work integrates behavioral science, ethics, and public health to enhance communication about reproductive health, genetics, and fertility preservation for individuals undergoing gonadotoxic treatment. She directs the NCI-funded ENRICH/ECHO training program, which improves oncology providers’ communication skills in reproductive and genetic health, and has contributed to national and international guidelines for ASCO, ASRM, and the PANCARE Life consortium. With more than 450 peer-reviewed publications—approximately 300 focused on reproductive health and bioethics—Dr. Quinn has significantly influenced research and practice in oncofertility, ethics, and cancer survivorship. She has served on the Board of Scientific Counselors for the National Institute of Environmental Health Sciences and holds fellowships in the American Association for Cancer Education and the New York Academy of Medicine. Her numerous honors, including the American Psychosocial Oncology Society’s Outstanding Education and Training Award, reflect her sustained leadership and impact on advancing equitable reproductive health care, ethical medical practice, and the education of future generations of researchers and clinicians worldwide.

Profiles: Google Scholar |Scopus | ORCID

Featured Publications

Loren, A. W., Mangu, P. B., Beck, L. N., Brennan, L., Magdalinski, A. J., Partridge, A. H., … & Quinn, G. P. (2013). Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology, 31(19), 2500–2510. Cited by: 1,901

Oktay, K., Harvey, B. E., Partridge, A. H., Quinn, G. P., Reinecke, J., Taylor, H. S., … & Loren, A. W. (2018). Fertility preservation in patients with cancer: ASCO clinical practice guideline update. Journal of Clinical Oncology, 36(19), 1994–2001. Cited by: 1,663

Quinn, G. P., Sanchez, J. A., Sutton, S. K., Vadaparampil, S. T., Nguyen, G. T., Green, B. L., … & Schabath, M. B. (2015). Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA: A Cancer Journal for Clinicians, 65(5), 384–400. Cited by: 551

Quinn, G. P., Vadaparampil, S. T., Lee, J. H., Jacobsen, P. B., Bepler, G., Lancaster, J., & Keefe, D. L. (2009). Physician referral for fertility preservation in oncology patients: A national study of practice behaviors. Journal of Clinical Oncology, 27(35), 5952–5957. Cited by: 490

Nahata, L., Tishelman, A. C., Caltabellotta, N. M., & Quinn, G. P. (2017). Low fertility preservation utilization among transgender youth. Journal of Adolescent Health, 61(1), 40–44. Cited by: 345

 

Dr. Gwendolyn P. Quinn’s pioneering work in reproductive ethics, patient–provider communication, and oncofertility has transformed clinical practice and education worldwide, advancing equitable reproductive health care for cancer patients and sexual and gender minorities. Her research and training initiatives have shaped global guidelines and strengthened ethical, compassionate communication in medicine.

Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Published on by Global Scholar Awards

Dr. Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Specialist | University of health sciences | Turkey

Dr. Nermin Mutlu Bilgic is a Gastroenterology Specialist at the University of Health Sciences Ümraniye Training and Research Hospital in Istanbul, Türkiye. She earned her Doctor of Medicine degree from Istanbul University Cerrahpaşa Faculty of Medicine in 2004, completed her residency in Internal Medicine at Maltepe University between 2007 and 2012, and obtained her subspecialty in Gastroenterology at Ümraniye Training and Research Hospital from 2015 to 2019. With over fifteen years of academic and clinical experience, Dr. Bilgiç specializes in hepatology, metabolic liver diseases, and inflammatory gastrointestinal disorders. She has served as Principal Investigator for international multicenter clinical trials evaluating the efficacy and safety of Saroglitazar Magnesium in patients with Primary Biliary Cholangitis and Nonalcoholic Steatohepatitis, reflecting her active contribution to global research in liver diseases. She has received certified training in Good Clinical Practice (GCP) from Roche/Genentech and the Global Health Training Centre, ensuring compliance with international ethical and regulatory standards. Dr. Bilgiç has authored and co-authored peer-reviewed publications and presented her work at several national and international gastroenterology and internal medicine conferences. Her professional focus integrates patient-centered clinical care with translational research aimed at improving therapeutic outcomes and understanding the mechanisms of chronic liver disease. She is also actively engaged in mentoring residents and fellows, contributing to medical education and the advancement of clinical research culture within her institution. Through her leadership in clinical trials, scientific collaborations, and commitment to ethical medical practice, Dr. Nermin Mutlu Bilgiç continues to make a meaningful impact on the advancement of gastroenterology and hepatology in both national and international contexts.

Profiles: Google Scholar | ORCID

Featured Publications

Kul, S., Caliskan, Z., Guvenc, T. S., Celik, F. B., Sarmis, A., Atici, A., Konal, O., Akıl, M., & Bilgiç, N. M. (2023). Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with …. Microvascular Research, 146, 104458 Cited by 31

Sayar, S., Aykut, H., Kaya, Ö., Kürbüz, K., Ak, Ç., Gökçen, P., Bilgiç, N. M., Adalı, G., & others. (2021). Bone mineral density screening and the frequency of osteopenia/osteoporosis in Turkish adult patients with celiac disease. The Turkish Journal of Gastroenterology, 32(7), 600–606 Cited by 13

Sayar, S., Kürbüz, K., Kahraman, R., Öztürk, O., Çalışkan, Z., Doğanay, H. L., Bilgiç, N. M., & others. (2020). Risk of hepatitis B reactivation during anti-TNF therapy: Evaluation of patients with past hepatitis B infection. The Turkish Journal of Gastroenterology, 31(7), 522–528 Cited by 13

Ozdil, K., Ozturk, O., Çalık, E. S., Akbas, E. S., Kanat, E., Caliskan, Z., Demirdag, H., Bilgiç, N. M., & others. (2016). Relationship between size of varices and platelet count/spleen size ratio in cirrhotic patients. Northern Clinics of Istanbul, 3(1), 46–50 Cited by 11

Adali, G., Bilgiç, N. M., Kalaman, A. E., Ozturk, O., & Ozdil, K. (2023). Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study. Hepatology Forum, 4(3), 129–135 Cited by 8

 

Dr. Nermin Mutlu Bilgic work advances the understanding and management of chronic liver and metabolic diseases through evidence-based clinical research and international collaboration. Her contributions to hepatology and gastroenterology foster improved patient outcomes, support ethical research practices, and drive innovation in global liver health.

Aylin Köseler | Medicine | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Aylin Köseler | Medicine | Best Researcher Award

Professor | Pamukkale University Medical Faculty | Turkey

Professor Aylin Köseler is a distinguished academic in the field of biophysics and molecular genetics, currently serving in the Department of Biophysics at Pamukkale University Faculty of Medicine. Her extensive research career spans over two decades, focusing on the molecular mechanisms underlying genetic variability, pharmacogenomics, and disease susceptibility. She has made significant contributions to understanding gene–environment interactions, genetic polymorphisms, and epigenetic regulations associated with cardiovascular diseases, metabolic disorders, and infectious diseases such as COVID-19. Prof. Köseler has led and participated in numerous national and international research projects, including collaborations with prestigious institutions such as Harvard Medical School and the University of California, Los Angeles (UCLA). Her notable involvement in projects like Whole Genome Sequencing of Ancient DNA and Epigenetics in Identical Twins and COVID-19 Patients demonstrates her commitment to interdisciplinary science bridging genetics, biophysics, and clinical medicine. Throughout her academic tenure, she has supervised graduate research and contributed to advancing biomedical science through experimental and computational biophysics approaches. She has authored and co-authored numerous peer-reviewed publications and presented her work at scientific conferences worldwide. Her research outputs have been recognized for their scientific rigor and impact on personalized medicine, population genetics, and evolutionary biology. Beyond academic excellence, Prof. Köseler’s work has substantial societal implications, particularly in improving diagnostic precision, therapeutic efficacy, and public health outcomes. Her dedication to fostering young researchers and promoting collaborative innovation underscores her leadership in the Turkish and international scientific communities. Her ongoing projects continue to explore genetic determinants of complex diseases and epigenetic modulation, contributing valuable insights to the global biomedical research landscape.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Sabirli, R., Köseler, A., Goren, T., Turkcuer, I., & Kurt, O. (2021). High GRP78 levels in COVID-19 infection: A case-control study. Life Sciences, 265, 118781. https://doi.org/10.1016/j.lfs.2020.118781 — Cited by: 128

  2. Palmeira, A., Sousa, E., Köseler, A., Sabirli, R., Gören, T., Türkçüer, İ., Kurt, Ö., et al. (2020). Preliminary virtual screening studies to identify GRP78 inhibitors which may interfere with SARS-CoV-2 infection. Pharmaceuticals, 13(6), 132. https://doi.org/10.3390/ph13060132 — Cited by: 77

  3. Köseler, A., Sabirli, R., Gören, T., Türkçüer, İ., & Kurt, Ö. (2020). Endoplasmic reticulum stress markers in SARS-CoV-2 infection and pneumonia: Case-control study. In Vivo, 34(3 Suppl), 1645–1650. https://doi.org/10.21873/invivo.11938 — Cited by: 75

  4. Akca, H., Demiray, A., Yaren, A., Bir, F., Koseler, A., Iwakawa, R., Bagci, G., et al. (2013). Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer. Cancer Genetics, 206(3), 73–80. https://doi.org/10.1016/j.cancergen.2013.05.012 — Cited by: 58

  5. Atalay, E. Ö., Koyuncu, H., Turgut, B., Atalay, A., Yildiz, S., Bahadir, A., & Köseler, A. (2005). High incidence of Hb D-Los Angeles [β121 (GH4) Glu→ Gln] in Denizli Province, Aegean region of Turkey. Hemoglobin, 29(4), 307–310. https://doi.org/10.1080/03630260500217438 — Cited by: 50

Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Published on by Global Scholar Awards

Prof. Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Professor in Medicine and Immunology | N.D. Zelinskii Institute for Organic Chemistry | Russia

Prof. Sergey V. Suchkov, MD, PhD, is a distinguished physician-scientist and international leader in immunology, personalized and precision medicine, and biodesign. Born in Astrakhan, Russia, he graduated with an MD from Astrakhan State Medical University in 1980 and earned his PhD from Sechenov University in 1985, followed by a Doctor’s Degree from the National Institute of Immunology in 2002. His professional experience spans over four decades, including senior research positions at the USSR Academy of Medical Sciences, the Moscow Clinical Research Institute (MONIKI), and leadership roles as Director of the Center for Personalized & Precision Medicine at Sechenov University, Vice-Director of the Institute for Biotech & Global Health at RosBioTech National University, and Director of the Center for Biodesign at N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences. He has contributed to international collaborations, with advanced training and research engagements at the NEI, NIH, USA, Wills Eye Hospital, Philadelphia, and invited work at several British universities under the Royal Society for Immunology. Prof. Suchkov’s research interests include clinical immunology, predictive and preventive medicine, precision nutrition, and translational biodesign, underpinned by skills in immunobiotechnology, personalized therapy design, clinical trial management, and biomedical innovation. He has authored numerous publications in reputed journals and conferences (IEEE, Scopus-indexed) and actively participates in global professional societies including EPMA, ISPM, PMC, ACS, AHA, ARVO, ISER, and AMEE. Recognized for his leadership and contributions to medical education and clinical practice, he has received multiple honors and holds key advisory roles in international research organizations. Prof. Suchkov’s exceptional expertise, global collaborations, and mentorship capacity position him to advance personalized medicine and immunology research worldwide, foster innovation, and continue contributing to healthcare and scientific communities at the highest level, making him a highly deserving candidate for recognition and awards in his field. 989 Citations | 87 Documents | 12 h-index.

Profiles: Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Suchkov, S. V., Revishvili, A. S., Charchyan, E. R., & Belov, Y. V. (2025). Towards highly precise treatment and rehabilitation in practice of modern cardiologist, cardiac surgeon and cardiac rehabilitation professional.

  2. Suchkov, S. V., Charchyan, E. R., Polyakova, V. N., & Belov, Y. V. (2025). On the path to personalized cardiology: prospects of precise assessment of cardiovascular risks and predictive-prognostic diagnostics.

  3. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 2. Ecological Comfort as a New and Strategic Factor in the Protection of Modern Human Health.

  4. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 1. Engineering and Design Resources of the Bioindustry on the Way to Safe Competition with the Resources of Natural Biocenoses and Health-Saving Systems.

  5. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Health, Environmental Comfort and Wellbeing through the Integration of Natural and Engineering-Design Bioresources: At the Junction of Pharmaco- and Nutriodesign to the Bioindustry of Tomorrow.

Kyung Jun Heo | Reconstructive Surgery | Best Researcher Award

Published on by Global Scholar Awards

Dr. Kyung Jun Heo | Reconstructive Surgery | Best Researcher Award

Resident | Kyung Hee University | South Korea

Dr. Kyung Jun Heo, M.D., is a dedicated clinician-scientist in the field of plastic and reconstructive surgery, currently serving as a Resident at the Department of Plastic and Reconstructive Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. He completed his B.S. in Medical Science at Kyung Hee University in 2014, followed by his M.D. from Chung-Ang University College of Medicine in 2019. Professionally, he has served as a Public Health Doctor at Anseong City Public Health Center (2019–2022), where he played a critical role as an epidemiological investigator during the COVID-19 pandemic and as an adverse events following immunization (AEFI) surveillance officer. His clinical and research interests span microsurgical reconstruction, particularly super-thin ALT and DIEP flaps for complex reconstructions, aesthetic and anti-aging medicine with a focus on collagen stimulators and fillers, and wound healing and scar biology, including keloid research and the role of α7 nicotinic acetylcholine receptor agonists. He has co-authored impactful publications, including work in Biomaterials (2012) and a recent article on the anti-fibrotic effects of α7nAChR agonists in keloid fibroblasts (2025), alongside multiple conference presentations at the Korean Society of Plastic and Reconstructive Surgeons (KSPRS) international congresses. His research skills include clinical trial design, microsurgical techniques, translational wound healing studies, and collaborative projects that bridge clinical innovation with molecular biology. Though early in his career, Dr. Heo has demonstrated leadership through both community service and academic engagement, supported by certifications in medicine and Basic Life Support. With 145 citations by 145 documents, 1 document indexed, and an h-index of 1, his academic footprint is steadily expanding. Driven by a commitment to advancing reconstructive techniques and improving patient outcomes, Dr. Heo shows strong promise for future contributions in high-impact research, international collaboration, and academic leadership, making him a valuable asset to the global medical research community.

Profiles: Scopus | ORCID 

Featured Publication

Jung, H. S., Pradhan, T., Han, J. H., Heo, K. J., Lee, J. H., Kang, C., & Kim, J. S. (2012). Molecular modulated cysteine-selective fluorescent probe. Biomaterials, 33(33), 8495–8502. Citations: ~ 143

Boya Guan | Medical Oncology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Boya Guan | Medical Oncology | Best Researcher Award

Pharmacist-in-charge​ at Tianjin Hospital | China

Boya Guan is a dedicated researcher and clinical pharmacist whose work bridges pharmacology, toxicology, and pharmaceutical sciences with a primary focus on osteosarcoma and bone cancer therapeutics. Over the course of her professional career, she has contributed significantly to oncology research by exploring drug mechanisms, drug resistance pathways, biomarker discovery, and clinical pharmacology applications. Her studies on triptolide-mediated ferroptosis and therapeutic strategies for overcoming drug resistance highlight her innovative approach to cancer research. Alongside her academic and clinical roles, she has been actively involved in translational projects that connect laboratory findings with patient care, ensuring that scientific discoveries lead to tangible clinical benefits. She has published in SCI-indexed journals, contributed to book chapters, and presented at national and international conferences, reflecting both the quality and impact of her work. With a strong commitment to research, innovation, and knowledge dissemination, she continues to shape advancements in oncology and pharmaceutical sciences.

Professional Profiles

Scopus Profile | ORCID Profile 

Education

Boya Guan has built a solid academic foundation that supports her extensive contributions to pharmaceutical research and clinical practice. She first pursued a degree in Pharmacy at Tianjin Medical University, where she developed a deep understanding of pharmacological principles and clinical applications. To expand her academic and professional horizons, she later completed a master’s program in Project and Operations Management at Southern New Hampshire University in the United States, equipping her with essential skills in management, leadership, and Six Sigma quality processes. This unique blend of pharmaceutical knowledge and operations management enabled her to approach research with a strategic and interdisciplinary perspective. She is currently advancing her expertise further by pursuing a master’s program in Pharmaceutical Analysis at Tianjin Medical University, focusing on advanced analytical methods and their role in clinical pharmacology. Her continuous academic development reflects her commitment to lifelong learning, professional growth, and scientific excellence in pharmaceutical sciences.

Experience

With over fourteen years of professional experience, Boya Guan has established herself as a highly skilled clinical pharmacist and researcher at Tianjin Hospital. In her role, she has been actively engaged in oncology-related pharmaceutical care, focusing on the mechanisms and efficacy of anticancer drugs while contributing to translational medicine initiatives. She has participated in significant clinical pharmacist training programs under the Tianjin Shortage Talent Program, where she deepened her expertise in oncology pharmacology and inpatient pharmaceutical care. Her experience is not limited to direct patient support; she has also been actively involved in clinical research, collaborating on projects that evaluate novel therapeutics such as denosumab for bone metastases and AI-based diagnostic tools. Beyond hospital-based responsibilities, she has presented her findings at conferences, published in peer-reviewed journals, and contributed book chapters, thereby extending her influence to both clinical and academic communities. Her experience reflects a balanced integration of research, practice, and innovation.

Research Interest

Boya Guan’s research interests lie at the intersection of oncology pharmacology, drug resistance mechanisms, and biomarker discovery, with a special focus on osteosarcoma therapeutics. She is particularly interested in investigating how targeted therapies and novel molecular pathways can overcome resistance to conventional drugs, thereby improving treatment outcomes for cancer patients. Her notable work includes exploring the role of triptolide in reversing cisplatin resistance through ferroptosis and lysosomal regulation, offering a promising therapeutic strategy. In addition to oncology, she is deeply engaged in analytical chemistry, employing dual-channel metabolomics and lipidomics approaches to identify biomarkers for diseases such as diabetes, thus contributing to early detection and precision medicine. She has also conducted systematic reviews and meta-analyses on VEGFR-TKIs in osteosarcoma, providing valuable evidence for clinical practice. Through her interdisciplinary approach, she aims to bridge pharmacology, translational research, and clinical application, ensuring her research has a meaningful and lasting impact on patient care.

Awards and Honors

Throughout her career, Boya Guan has earned recognition for her contributions to clinical pharmacy, research excellence, and innovative approaches to oncology therapeutics. She has been selected for prestigious programs such as the Tianjin Shortage Talent Program, which provided advanced clinical pharmacist training in oncology and inpatient care, underscoring her recognition as a promising specialist in pharmaceutical sciences. Her scientific contributions, including SCI-indexed journal publications, systematic reviews, and a book chapter on spinal metastases surgery, have also positioned her as a valuable contributor to academic and clinical communities. In addition to her professional achievements, she has been invited to present at multiple national and international conferences, where her research has been well received and acknowledged by peers. These honors reflect not only her strong academic and research background but also her potential to influence future directions in oncology and pharmaceutical research. Her growing recognition continues to strengthen her professional standing globally.

Research Skills

Boya Guan possesses a diverse range of research skills that combine laboratory expertise, clinical insight, and analytical methodologies. She is proficient in oncology pharmacology research, with specialized experience in studying drug resistance pathways, including ferroptosis-related mechanisms in osteosarcoma. Her analytical chemistry expertise includes metabolomics and lipidomics approaches for biomarker discovery, enabling her to contribute to the development of diagnostic and prognostic tools for complex diseases. She is skilled in conducting systematic reviews, meta-analyses, and clinical evaluations, ensuring evidence-based contributions to both research and practice. Additionally, she has demonstrated competence in designing and managing multidisciplinary research projects, including collaborations on AI-based diagnostic systems and drug efficacy studies. Her ability to translate laboratory findings into clinical strategies highlights her strength in bridging basic science with medical application. Coupled with strong writing, publication, and presentation skills, she is well-equipped to advance knowledge dissemination and foster innovation in oncology and pharmaceutical sciences.

Publication Top Notes

Title: Development of a dual-channel analytical approach for diabetic biomarker discovery in blood via integrative metabolomics and lipidomics
Year: 2025

Conclusion

Overall, Boya Guan is a highly deserving candidate for the Best Researcher Award. Her impactful contributions to osteosarcoma research, oncology pharmacology, biomarker discovery, and clinical drug evaluation showcase her ability to merge scientific innovation with real-world medical application. Her strong academic background, leadership in research, and commitment to improving cancer therapeutics reflect excellence in both scholarship and societal impact. With her continued focus on translational medicine and international collaborations, she holds significant potential to emerge as a global leader in oncology and pharmaceutical sciences.

Olympia Christofilea | Health Professions | Best Researcher Award

Published on by Global Scholar Awards

Mrs. Olympia Christofilea | Health Professions | Best Researcher Award

Deputy Chief Executive of 2nd RHA of Piraeus at University of West Attica | Greece

Dr. Olympia Christofilea is a highly accomplished professional and researcher in Public Health Policy and Healthcare Management, recognized for her expertise in occupational health, workplace safety, mental health, and healthcare workforce well-being. As Deputy Director of the 2nd Health Region of Piraeus and the Aegean, she plays a leading role in strengthening healthcare systems, designing strategic action plans, and improving healthcare delivery. She has made impactful contributions to the development of public health initiatives, crisis management strategies, and workforce sustainability programs. Her growing body of research, published in respected international journals, focuses on vital issues such as workplace quality of life, vaccination attitudes, and safety climate in healthcare settings. Combining her clinical background in nursing with advanced administrative and policy expertise, Dr. Christofilea bridges the gap between academic research and practical healthcare applications. Her leadership, research orientation, and multidisciplinary perspective make her a strong contributor to global health policy advancement.

Professional Profiles

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Olympia Christofilea has pursued an impressive educational journey that combines clinical training, administrative expertise, and advanced research. She is currently a Ph.D. candidate in the Department of Public Health Policy at the University of West Attica, focusing on critical issues in healthcare policy and occupational health. She holds a Master’s degree in Health Services Administration from the National School of Public Health, which has strengthened her ability to design and evaluate healthcare systems and policies. In addition, she possesses two undergraduate degrees: one in Nursing, which provides her with clinical and patient-centered insights, and another in Business Administration and Organization, equipping her with skills in management, planning, and organizational leadership. This unique combination of qualifications has provided her with a multidisciplinary foundation, enabling her to approach public health challenges with a balance of scientific rigor, clinical understanding, and policy-making acumen. Her education underpins both her research and leadership activities.

Experience

Dr. Olympia Christofilea brings extensive professional experience in healthcare management and public health administration, having held senior leadership roles in hospitals, regional health authorities, and the Ministry of Health. As Deputy Director of the 2nd Health Region of Piraeus and the Aegean, she has been responsible for overseeing primary healthcare and mental health services, while actively shaping strategies to strengthen health systems. She has participated in inter-ministerial working groups and international collaborations, contributing to the design of policies and funding programs aimed at improving healthcare access and quality. Her work includes crisis management in healthcare, strategic planning, and the implementation of occupational health and safety measures for healthcare professionals. This professional track record demonstrates her ability to translate research into real-world solutions that enhance workforce well-being and patient outcomes. Through her administrative leadership and evidence-based approach, she has consistently influenced health policy at both national and regional levels.

Research Interest

Dr. Olympia Christofilea’s research interests lie at the intersection of public health, occupational safety, and healthcare workforce management. She is particularly focused on understanding and improving workplace safety climates, promoting healthcare workers’ quality of life, and addressing mental health challenges in high-demand healthcare settings. Another key area of her research involves vaccination policies and practices, especially concerning vulnerable populations such as migrants and refugees, highlighting her commitment to equity in public health. Her studies also emphasize the importance of workforce sustainability and the development of policies that safeguard healthcare professionals from burnout, stress, and workplace hazards. With her combined background in nursing, administration, and health policy, she integrates clinical insight with management strategies to produce research that is both academically rigorous and socially relevant. By prioritizing applied research with direct implications for health policy and practice, her work contributes meaningfully to the improvement of healthcare systems worldwide.

Awards and Honors

Dr. Olympia Christofilea has earned recognition for her contributions to healthcare leadership, public health research, and service management. While currently advancing her academic career through her Ph.D. and research publications, she has already established herself as a respected figure in health policy circles. Her active participation in inter-ministerial committees, international collaborations, and healthcare reform initiatives reflects the trust placed in her expertise and leadership skills. She has been acknowledged through invitations to working groups and collaborative platforms that shape health policies at regional and national levels. Additionally, her publications in reputable international journals stand as academic recognition of her ability to address critical issues in occupational health and safety, mental health, and healthcare workforce management. As her research profile continues to grow, she is well-positioned to receive further academic honors, keynote invitations, and professional distinctions that acknowledge her impact on healthcare systems and public health development.

Research Skills

Dr. Olympia Christofilea possesses strong research skills spanning quantitative, qualitative, and policy-oriented methodologies. She has demonstrated expertise in designing and conducting cross-sectional and case study research focused on healthcare systems, workplace safety, and occupational health. Her ability to analyze large-scale demographic and job-related data has contributed to evidence-based recommendations for improving healthcare workforce quality of life. She is skilled in survey design, statistical analysis, and systematic review techniques, which she applies to investigate complex healthcare challenges. In addition, her collaborative work with multidisciplinary teams highlights her competence in project coordination, academic writing, and dissemination of research findings through high-quality journals. She is adept at linking research outcomes with practical policy recommendations, ensuring her work has both academic and social impact. Her research skills extend beyond traditional scholarship to applied problem-solving, making her contributions particularly valuable to public health policy, workforce management, and healthcare service optimization.

Publication Top Notes

Title: Vaccination of healthcare workers against influenza: does a day off make a difference?
Authors: HC Maltezou, O Christophilea, A Tedoma, P Katerelos, G Dounias
Year: 2018
Citations: 14

Title: Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection
Authors: L Psaridi, HC Maltezou, S Simonidou, I Lialliou, D Athanasopoulou, …
Year: 2022
Citations: 9

Title: Assessment of Workplace Safety Climate among Healthcare Workers: A Case Study of the Public Sector Hospitals in Greece
Authors: O Christofilea, G Farantos, L Psaridi, M Tsaousi, S Sartzi, G Dounias
Year: 2025
Citations: 1

Title: Assessment of Workplace Safety Climate among Healthcare Workers: A Case Study of the Public Sector Hospitals in Greece
Authors: O Christofilea, G Farantos, L Psaridi, M Tsaousi, S Sartzi, G Dounias
Year: 2024
Citations: 1

Title: Demographic and Job-Related Predictors of Work-Related Quality of Life Among Healthcare Workers: Evidence from Public Sector Hospitals in Greece
Authors: O Christofilea, M Tsaousi, L Psaridi, P Sourtzi, V Papanikolaou, …
Year: 2025
Citations: –

Title: Hospital occupational health and safety services and accidents in Greek hospitals: A case study in a Greek health region
Authors: G Farantos, O Christofilea, G Dounias
Year: 2025
Citations: –

Title: Knowledge and attitudes of healthcare personnel about vaccination of migrant and refugee children and adolescents
Authors: Z Ouzounidou, HC Maltezou, K Chrysoula, E Polysiou, O Christofilea, …
Year: 2024

Conclusion

Overall, Olympia Christofilea is a highly suitable candidate for the Best Researcher Award. She combines rigorous academic research with hands-on leadership in public health, contributing significantly to healthcare workforce safety, public health policy, and health service management. Her scholarly publications, coupled with her administrative influence, show a clear commitment to improving both scientific knowledge and practical health outcomes. With her strong foundation and growing research trajectory, Olympia demonstrates not only past achievements but also immense future potential as a thought leader in public health research and policy.

Elena Popa | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Elena Popa | Medicine and Dentistry | Best Researcher Award

Lecturer at “Grigore T. Popa” University of Medicine and Pharmacy Iasi, Romania

Dr. Elena Popa is a distinguished Senior Lecturer at “Grigore T. Popa” University of Medicine and Pharmacy in Iași, Romania, with over 20 years of academic experience in Family and Preventive Medicine. Her research career, grounded in a Ph.D. on PPAR receptors and metabolic syndrome, has evolved to address critical public health issues such as chronic inflammation, Long COVID, and PCOS. She has published extensively in peer-reviewed journals and book chapters, actively contributing to national screening programs and interdisciplinary health initiatives. Dr. Popa uniquely integrates clinical practice with academic research, promoting evidence-based approaches in primary care. Her dedication to preventive strategies and translational research makes her a strong candidate for the Best Researcher Award. While further international collaboration and visibility of research metrics would enhance her profile, her impactful contributions to education, clinical practice, and public health firmly establish her as a leading figure in her field.

Professional Profile 

Education🎓

Dr. Elena Popa has a strong educational background in medical sciences, culminating in a Ph.D. in Medical Sciences obtained in 2014. Her doctoral research focused on “The Role of PPAR Receptors in Metabolic Syndrome,” demonstrating her early and sustained interest in the complex mechanisms underlying metabolic and inflammatory disorders. She pursued her medical education at the “Grigore T. Popa” University of Medicine and Pharmacy in Iași, Romania, where she currently serves as a Senior Lecturer. Over the years, Dr. Popa has continued to expand her knowledge through active participation in academic and professional development programs, including national and international conferences, workshops, and continuing medical education (CME) courses. Her academic journey reflects a commitment to both clinical excellence and research innovation, with a special focus on family medicine, preventive healthcare, and chronic disease pathophysiology. This solid educational foundation supports her role as both a researcher and a mentor in the medical field.

Professional Experience📝

Dr. Elena Popa has over two decades of professional experience in the fields of medical education, clinical practice, and research. She currently holds the position of Senior Lecturer in the Department of Preventive Medicine and Interdisciplinarity at the “Grigore T. Popa” University of Medicine and Pharmacy in Iași, Romania. In this role, she is deeply involved in teaching and mentoring medical students and residents, particularly in Family Medicine and Preventive Medicine. Alongside her academic duties, Dr. Popa maintains an active clinical practice as a family physician, enabling her to apply research insights directly to patient care. Her professional contributions also include involvement in national health screening programs, public health campaigns, and interdisciplinary healthcare initiatives. She frequently lectures at national conferences and continuing medical education programs, reinforcing her commitment to advancing healthcare knowledge and practice. Dr. Popa’s combined academic, clinical, and research roles exemplify her dedication to improving healthcare outcomes through integrated, evidence-based approaches.

Research Interest🔎

Dr. Elena Popa’s research interests center on the intersection of chronic inflammation, metabolic disorders, and public health. Her early work, initiated during her Ph.D. studies on the role of PPAR receptors in metabolic syndrome, laid the foundation for a broader exploration into inflammatory mechanisms underlying complex syndromes. She is particularly focused on conditions such as Long COVID and Polycystic Ovary Syndrome (PCOS), examining their links to endocrine dysfunction and systemic inflammation. Dr. Popa is also deeply engaged in preventive medicine, with an emphasis on improving primary care strategies and promoting early detection and intervention for chronic diseases. Her research bridges basic science and clinical application, aiming to translate findings into practical healthcare solutions. Through interdisciplinary collaboration and participation in national health programs, she seeks to enhance public health outcomes. Her work is characterized by a commitment to integrating medical research with education and community-based clinical practice.

Award and Honor🏆

Dr. Elena Popa has earned recognition and respect throughout her career for her outstanding contributions to medical education, clinical practice, and research. Her dedication to advancing preventive medicine and chronic disease management has been acknowledged through invitations to speak at numerous national conferences and continuing medical education (CME) programs. She has been honored for her active involvement in national health screening initiatives and interdisciplinary public health projects, which have had a meaningful impact on community health outcomes. As a mentor and educator, Dr. Popa has received commendations from academic institutions and professional organizations for her commitment to student training and resident development in family medicine. While specific awards are not explicitly listed, her sustained professional excellence, research productivity, and leadership in both academic and clinical settings reflect a career marked by distinction. Her reputation as a respected physician-researcher underscores her suitability for high-level academic and scientific honors, including the Best Researcher Award.

Research Skill🔬

Dr. Elena Popa possesses a comprehensive set of research skills that span both theoretical analysis and practical application in clinical and public health settings. Her expertise includes designing and conducting clinical and epidemiological studies, with a strong foundation in evidence-based medicine. She is adept at scientific writing, having authored and co-authored numerous peer-reviewed journal articles and book chapters focused on chronic inflammation, metabolic disorders, and preventive healthcare. Dr. Popa demonstrates skill in data interpretation, literature synthesis, and the integration of interdisciplinary perspectives, particularly in exploring the complex interactions between inflammation, endocrine dysfunction, and chronic disease. Her ability to translate research findings into real-world clinical strategies highlights her strength in translational research. Additionally, she effectively collaborates across academic and healthcare sectors, contributing to national screening programs and health initiatives. Her dual roles as a practicing physician and academic researcher enable her to apply rigorous scientific inquiry directly to patient care and healthcare improvement.

Conclusion💡

Dr. Elena Popa is a highly qualified and impactful candidate for the Best Researcher Award, especially for domains focused on preventive medicine, chronic disease pathophysiology, and translational clinical research. Her blend of long-term academic involvement, interdisciplinary focus, and commitment to applying research in clinical settings is commendable.

Publications Top Noted✍️

  • The Significance of Low Magnesium Levels in COVID-19 Patients

    • Authors: EA Coman, A Ceasovschih, AD Petroaie, E Popa, C Lionte, C Bologa, …

    • Year: 2023

    • Citations: 21

  • Stress: from symptom to disease

    • Authors: MG Traian, AE Coman, L Traian, R Petrovanu

    • Year: 2013

    • Citations: 8

  • Epidemiological study of metabolic syndrome and risk of diabetes mellitus in a rural family medicine practice in Bacau County

    • Authors: D Alamir, P Elena, A Bacusca, MG Traian, R Petrovanu, AE Coman

    • Year: 2014

    • Citations: 5

  • Flow Cytometry Analysis of Pparα Receptors in Metabolic Syndrome

    • Authors: E Popa, F Zugun-Eloae, M Zlei, D Jitaru, OM Pintilie, AE Coman, M Traian, …

    • Year: 2014

    • Citations: 4

  • Non-invasive Serological Markers of Hepatic Fibrosis – Mini Review

    • Authors: E Popa, RI Avram, AE Popa, AE Coman

    • Year: 2024

    • Citations: 3

  • PEX6 Mutation in a Child with Infantile Refsum Disease—A Case Report and Literature Review

    • Authors: AM Slanina, EA Coman, D Anton-Paduraru, E Popa, CL Barbacariu, …

    • Year: 2023

    • Citations: 3

  • Pelvic inflammatory disease

    • Authors: E Popa, AA Chis-Srban, C Manole, A Coman

    • Year: 2019

    • Citations: 3*

  • O analiza SWOT a rezultatelor screeningului de cancer de col uterin (2012–2016)

    • Authors: G Calfa, E Popa, D Pletea, M Grigore, I Pavaleanu

    • Year: 2016

    • Citations: 3

  • The “Viral” Form of Polyarteritis Nodosa (PAN)—A Distinct Entity: A Case Based Review

    • Authors: V Pasa, E Popa, M Poroch, A Cosmescu, AI Bacusca, AM Slanina, …

    • Year: 2023

    • Citations: 2

  • The Effects of the COVID-19 Pandemic on Mental Health: A Web-Based Study Among Romanian Adults

    • Authors: E Popa, T Tetia, M Poroch, AE Coman

    • Year: 2022

    • Citations: 2

  • Methods of internet addiction screening for teens and young adults in Primary Care

    • Authors: AM Slanina, AD Petroaie, C Nasaudean, AI Bacusca, U Monica, …

    • Year: 2021

    • Citations: 2

  • Disfuncția endotelială – de la mecanisme moleculare la cuantificare și tratament în practica medicală

    • Authors: E Popa, MG Traian, A Bacusca, A Diaa, R Petrovanu, AE Coman

    • Year: 2014

    • Citations: 2

Felicia Antohe | Health Professions | Excellence in Research

Published on by Global Scholar Awards

Dr. Felicia Antohe | Health Professions | Excellence in Research

Head of Proteomics Department at Inst. Cellular Biology and Pathology NS, Romania

Dr. Felicia Antohe, a distinguished researcher and Head of the Proteomics Department at the Institute of Cellular Biology and Pathology, Romanian Academy, is a highly suitable candidate for the Excellence in Research Award. With a Ph.D. in Cellular Biology and over 170 scientific publications, including 90 indexed in Web of Science and over 2,500 citations, she has made significant contributions to biomedical sciences. Her expertise spans proteomics, vascular biology, monoclonal antibody technology, and molecular mechanisms of macromolecular transport. Dr. Antohe has led over 44 national and international research projects, mentored numerous Ph.D. students, and held key roles in prestigious European scientific committees, including as an expert evaluator for EC Framework Programs. Recognized globally with multiple international awards and fellowships, her work has advanced knowledge in atherosclerosis, immune disorders, and endothelial cell biology. Her strong leadership, innovative research, and dedication to scientific excellence make her an exemplary candidate for this honor.

Professional Profile 

Education🎓

Dr. Felicia Antohe holds a robust academic background in the life sciences, beginning with a Master’s degree in Biophysics from the University of Bucharest, Faculty of Physics, completed between 1972 and 1977. She later pursued her doctoral studies at the Romanian Academy’s Institute of Cellular Biology and Pathology (IBPC N. Simionescu), where she earned a Ph.D. in Cellular Biology between 1985 and 1994. In 2000, she was accredited as a Ph.D. Coordinator in Cellular Biology by the Romanian Academy and the Ministry of Education and Research. Her education has been complemented by extensive international training and research fellowships at prestigious institutions such as McGill University (Canada), University of Alberta (Canada), Max Planck Institute (Germany), and Université René Descartes (France), among others. This rich educational foundation has equipped Dr. Antohe with interdisciplinary expertise spanning biophysics, molecular biology, immunology, and proteomics, laying the groundwork for her prolific and impactful scientific career.

Professional Experience📝

Dr. Felicia Antohe has an extensive and distinguished professional background in biomedical research, currently serving as Head of the Proteomics Department at the Institute of Cellular Biology and Pathology “N. Simionescu” of the Romanian Academy. She has also led the Monoclonal Antibody Laboratory and serves as a Ph.D. Coordinator in Cellular Biology. With over four decades of experience, she has acted as Principal Investigator on more than 44 nationally and internationally funded research projects and has mentored numerous Ph.D. and postgraduate students. Her international experience includes research fellowships and visiting scientist roles at top institutions such as McGill University, University of Alberta, Max Planck Institute, and Université René Descartes. She has served as an expert evaluator for EU Framework Programs (FP6, FP7), contributed to national research councils, and held leadership roles in international scientific networks like COST and the Central and Eastern European Proteomic Conferences. Her work integrates academic leadership with pioneering research.

Research Interest🔎

Dr. Felicia Antohe’s research interests lie at the intersection of cellular biology, molecular biology, and biomedical sciences, with a particular focus on the vascular endothelium. Her work explores the molecular mechanisms of macromolecule transport across endothelial cells, including transcytosis and endocytosis, in both healthy and pathological conditions such as atherosclerosis, diabetes, and immune disorders. She is deeply engaged in the study of membrane microdomains—lipid rafts and caveolae—and their structural and functional roles in cellular signaling and transport. Dr. Antohe is also an expert in proteomics, utilizing mass spectrometry and bioinformatics to analyze endothelial cell proteins in health and disease. Her research extends into the biotechnology of monoclonal and polyclonal antibodies for diagnostic and therapeutic applications. With a strong foundation in immunochemistry, molecular diagnostics, and nanostructured materials, her interdisciplinary investigations contribute to advancing biomedical knowledge and improving clinical strategies for vascular and systemic inflammatory diseases.

Award and Honor🏆

Dr. Felicia Antohe has received numerous prestigious awards and honors in recognition of her outstanding contributions to biomedical research. Internationally, she was awarded the EURESCO Prize for her work on membrane dynamics, and received the BIO-RAD Laboratories Prize for valuable scientific contributions. Her research has been recognized with the IIIrd Award at the International Congress of Medical Sciences in Bulgaria, and the Best Poster Award at the 8th International Conference on Vascular Endothelium in Greece. She has also earned fellowships, including the ESF grant for EURESCO Conferences and a Summer School Fellowship in Scotland. Nationally, she received the esteemed Emil Racoviță Prize from the Romanian Academy and eight other awards from institutions such as the University of Bucharest and CNCSIS. Additionally, she has been an invited speaker at numerous global conferences and authored monographs featured in over 1,900 international libraries, cementing her influence in the scientific community.

Research Skill🔬

Dr. Felicia Antohe possesses an exceptional array of research skills, developed through decades of pioneering work in cellular biology and proteomics. Her technical expertise encompasses a broad range of advanced methodologies, including immunological techniques such as monoclonal antibody production, FACS, ELISA, and immunocytochemistry. She is highly proficient in molecular biology tools, including PCR, RT-qPCR, in situ hybridization, and plasmid transfection. Dr. Antohe is also skilled in cell biology practices like cell culture, fluorescence and electron microscopy, and animal modeling. Her proteomics capabilities include 1D and 2D SDS-PAGE, protein radio-labeling, scintillation and gamma counting, and mass spectrometry, coupled with strong bioinformatics analysis. She has also applied her knowledge to complex systems such as lipid rafts, transcytosis, and membrane receptor function. In addition to hands-on techniques, she excels in mentoring young scientists and PhD students, reflecting her strong leadership in research training and laboratory development.

Conclusion💡

Dr. Felicia Antohe is highly suitable for an Excellence in Research Award, particularly one recognizing:

  • Lifetime achievements

  • Biomedical innovation

  • Mentorship

  • Leadership in research ecosystems

Her academic depth, scientific rigor, and institutional leadership align strongly with the core mission of such an award. While certain modern metrics (e.g., recent societal impact or innovation transfer) could be elaborated more, these are secondary when weighed against the breadth and depth of her contributions.

Publications Top Noted✍️

  • Firan M., Bawdon R., Radu C., Ober R.J., Eaken D., Antohe F., Ghetie V., et al. (2001). The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans. International Immunology, 13(8), 993–1002.
    📌 Citations: 404

  • Borvak J., Richardson J., Medesan C., Antohe F., Radu C., Simionescu M., et al. (1998). Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. International Immunology, 10(9), 1289–1298.
    📌 Citations: 308

  • Simionescu M., Gafencu A., Antohe F. (2002). Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microscopy Research and Technique, 57(5), 269–288.
    📌 Citations: 272

  • Antohe F., Rădulescu L., Gafencu A., Gheţie V., Simionescu M. (2001). Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Human Immunology, 62(2), 93–105.
    📌 Citations: 204

  • Van Gool A., Corrales F., Čolović M., Krstić D., Oliver-Martos B., Antohe F., et al. (2020). Analytical techniques for multiplex analysis of protein biomarkers. Expert Review of Proteomics, 17(4), 257–273.
    📌 Citations: 95

  • Simionescu M., Antohe F. (2006). Functional ultrastructure of the vascular endothelium: changes in various pathologies. In: The Vascular Endothelium I, pp. 41–69.
    📌 Citations: 90

  • Manduteanu I., Voinea M., Antohe F., Dragomir E., Capraru M., Radulescu L., et al. (2003). Effect of enoxaparin on high glucose-induced activation of endothelial cells. European Journal of Pharmacology, 477(3), 269–276.
    📌 Citations: 85

  • Lixandru B.E., Cotar A.I., Straut M., Usein C.R., Cristea D., Ciontea S., Antohe F., et al. (2015). Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey. PLoS ONE, 10(11), e0143214.
    📌 Citations: 66

  • Antohe F., Dobrila L., Heltianu C., Simionescu N., Simionescu M. (1993). Albumin-binding proteins function in the receptor-mediated binding and transcytosis of albumin across cultured endothelial cells. European Journal of Cell Biology, 60(2), 268–275.
    📌 Citations: 66

  • Haraba R., Suica V.I., Uyy E., Ivan L., Antohe F. (2011). Hyperlipidemia stimulates the extracellular release of the nuclear high mobility group box 1 protein. Cell and Tissue Research, 346, 361–368.
    📌 Citations: 53